http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110741290-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K2019-0448
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03B21-604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-588
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-3852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G02B5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-586
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C09K19-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G03B21-60
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B5-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G02B5-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C09K19-54
filingDate 2018-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2022-03-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-110741290-B
titleOfInvention Liquid crystal composition, method for producing reflective layer, cured product, and optically anisotropic body
abstract The 1 st object of the present invention is to provide a liquid crystal composition capable of forming a reflective layer having excellent diffuse reflectivity. Another object of the present invention is to provide a method for producing a reflective layer having excellent diffuse reflectance and a reflective layer having excellent diffuse reflectance. The 3 rd object of the present invention is to provide a cured product and an optically anisotropic body formed by using the liquid crystal composition. The liquid crystal composition of the present invention comprises a liquid crystal compound, a chiral agent a for reducing helical twisting power by light irradiation, and a chiral agent B for inducing a helix in a direction opposite to that of the chiral agent a, and when the liquid crystal compound is aligned to be in a cholesteric liquid crystal phase, cholesteric alignment is performed in a direction of the helix induced by the chiral agent B.
priorityDate 2017-07-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1286188-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1301823-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005019379-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002267830-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2010145211-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2002338575-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7158297-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008250187-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2003082352-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22732251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11762
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456438065
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394306
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408299504
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414875128
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12597
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415863310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415742662
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522942
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444539
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419524464
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452624497
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7488
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546310
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID171378
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7189
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394277
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546720
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415741734
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID69410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526415
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID162822
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415858996
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394802
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID14265

Total number of triples: 57.